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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is commonly misdiagnosed in the early stages, because it has 
multiple nonspecific signs and symptoms as well as a difficult anatomic site. Especially if there is a comorbid 
in the area around the nasopharynx, it will most likely be misdiagnosed. This results in a high mortality rate due 
to it being diagnosed in a later advanced stage. Therefore it is important for physicians to recognize early signs 
and symptoms of this case and know the differential diagnosis. 
Case report: Reported a 58 year old male with history of recurrent nasal bleeding, accompanied by hearing problem 
and ear fullness. He also complained of a severe headache as well as the appearance of a left neck mass since a few 
months prior. During nasopharyngocopy a gelatinous mass in the right nasal cavity and a nasopharyngeal mass 
extending to both nasal cavities was found. The biopsy results were polyp nasi Hellquist Type I and Undifferentiated 
Nonkeratinizing Carcinoma. CT with contrast showed the nasopharyngeal mass has extended intracranially. Patient 
was planned to undergo polypectomy followed by chemoradiation. Despite the tumor having radiosensitive 
properties, the prognosis and the survival rate are low because the patient came at stage IV.  
Conclusion: Early sign and symptoms of NPC should be known by health workers so they can recognize and 
refer NPC at an early stage. 
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1. CASE REPORT 
Nasopharyngeal carcinoma is commonly misdiagnosed during the early 
stages because it has nonspecific signs and symptoms. It is also located in 
the nasopharyngeal area which is difficult to assess for a physical 
examination. This results in an advanced stage diagnosis and a high 
mortality rate Even though the tumor is radiosensitive, it still has a high 
morbidity. Around 60-85% of NPC patients already has cervical lymph 
nodes or distant metastasis at the time of diagnosis. This article reports an 
advanced nasopharyngeal cancer with a nasal polyp comorbid in which it 
further impedes diagnosis, especially at a primary health care facility. 
Therefore, further educating health workers is important. 
Mr. W, 58 years old, came with complaints of nosebleed since 3 days 
ago. Nosebleeds appeared suddenly from both nostrils flowing to 
approximately half a starfruit glass per day and lasts about a few minutes 
and was quite disturbing. Complaints were accompanied by a chronic runny 
nose, sometimes accompanied by thick yellow or green snot or a blood line, 
a bad smell from the nose, and nasal congestion. Olfaction was slightly 
reduced and he was prone to sneezing when exposed to dust. 
Complaints were also accompanied by hearing loss and aural fullness 
in both ears since 11 months prior. Complaints of aural discharge, tinnitus 
or pain from both ears were denied. 
Patient also complained of a severe headache felt since 4 months ago. 
Double-vision, visual disturbances, hoarseness, feeling of thickness on the 
cheeks, dyspnea and dysphagia were denied. 
A lump located at the left neck appeared around 2 months prior. 
Initially, the lump size was as big as a nut and it grew to approximately a 
chicken egg. The lump was painless. Lumps in other areas were denied. 
A history of recurring nosebleeds since the previous 6 months was 
reported. There were no history of hypertension, Diabetes Mellitus and 
weight loss. History of similar diseases in the family was denied. Chronic 
cold history and asthma in the family were denied. There was history of 
eating salty fish since childhood and old smoking habits was recognized, the 
habit of drinking liquor is denied. History of sneezing, nasal congestion and 














Picture 1. Examination of Neck Region 
On general examination, it was found that the general condition was 
good BP 120/80 mmHg, pulse 80x/minute, RR 24x/minute, temperature 
370C. Examination of ear and throat were within normal limit. In the nasal 
cavity there was a blood clot, inferior turbinate were livid and hypertrophy 
was found in both nasal cavities, accompanied by a decrease in the right air 
passage. Examination of the face and cranial nerves was within normal 
limits. Then the neck examination obtained a mass on left neck at level II 
(upper jugular), the surface was smooth, mobile, hard consistency, no 











Picture 2. A. Polip in Right Nasal Cavity (red arrow) and Nasopharyngeal 
Mass (black arrow), B. Left Nasopharyngeal Mass (black arrow). 
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The patient was diagnosed with suspected nasopharyngeal carcinoma 
with right nasal polyp. Nasopharyngoscopy evaluation was performed per 
local anesthetic which found a gelatinous mass in the right nasal cavity and 
a reddish mass of the nasopharynx which has extended to both nasal cavities. 







Picture 3. CT Scan with contras 
Nasopharyngeal CT scan with contrast was obtained with impression 
that there was a thickening of both nasopharyngeal posterior wall extending 
to both sphenoid sinus, anteriorly infiltrating the nasal cavities, especially 
the right cavity, superiorly infiltrating intracranially through the cavernous 
sinus. Accompanied by both maxillary sinusitis and enlargement of the left 
neck node. Examination of chest x-ray and abdominal hepatobiliary 














Picture 4. Anatomi Patology: A. Polyp B. Undifferentiated Carcinoma 
The results of histopathological were obtained, with the conclusion that 
the preparation number A is Type I Hellquist Nasal Polyp and preparation 
number B is Nonkeratinizing Carcinoma, Undifferentiated type. In 
conclusion the patient was diagnosed with Undifferentiated Nasopharyngeal 
Carcinoma that had extended to intracranial with metastases to left neck 
lymph node T4N2Mx (stage 4A), accompanied by chronic rhinosinusitis 
with right nasal polyp. Patient was planned for a polypectomy and chemo-
radiation. 
2. DISCUSSION 
Along with the increasing access to health services in Indonesia through 
the JKN (National Health Insurance) government program, even more cases 
of malignancy are found in the regions. Malignancy in ENT field especially 
nasopharyngeal cancer is still a case that is difficult to diagnose at an early 
stage, considering a number of symptoms and early clinical signs that are 
not specific. In addition anatomically, the position of the nasopharynx is 
very difficult to examine without using special equipment. Even some 
adequate equipment is still relatively expensive so not all health facilities in 
Indonesia are able to inspect it, especially first-level health facilities as the 
spearhead of JKN-based services. 
 Nasopharyngeal carcinoma is malignancy originating from the 
epithelium or mucosa and crypts that line the nasopharynx surface [1]. The 
initial lesion of malignancy lies in the Rosenmuller fossa, which is a 
squamous cell epithelium around the Eustachian tube, the lateral wall and 
















Picture 5. Anatomic Site and Subsite of the Head and Neck, Nasopharynx 
Area [5]. 
The incidence of NPC in Indonesia is estimated at 6.2 cases per 100,000 
population per year [6]. About 60% of malignant neck head tumors are NPC 
which ranks fifth of all malignancies after malignant cervical, breast, lymph 
node, and skin tumors [7]. Nasopharyngeal carcinoma can be found at all 
ages, but rarely under 20 years. The incidence of NPC starts to increase at 
the age of 20-24 years and is often found in the productive age of 30-59 
years (around 80%) with a peak between 40-49 years [8]. NPC events are 
more common in men than women by comparison 2-3:1 [9]. The patient was 
a 58-year-old male, this patient was well suited to epidemiological profiles 
in most cases. 
Nasopharyngeal carcinoma is a complex disease caused by the 
interaction of genetic, environmental, and chronic infections of VEB 
(Epstein Barr Virus) [10, 11]. Several studies in the population for decades 
found that the nasopharynx is susceptible to smoking/tobacco; smokers have 
an increased risk of NPC 30%-100% compared to nonsmokers. Incomplete 
combustion smoke particles from coal, wood, and other materials can also 
be deposited in the nasopharynx [11]. Marinated fish and other preserved 
foods contain large amounts of nitrosodimethyamine (NDMA), N-
nitrospyrrolidene (NPYR), and N-nitrospiperidine (NPIP) which are the 
factors of NPC carcinogens. Salted fish exposure at an early age at high risk 
of NPC in South Chinese people [12, 13]. Primary EBV infection is common 
in early childhood, asymptomatic but produces a persistent virus throughout 
life. The EBV has a strong response to human lymphocytes and upper 
airway epithelium. Oropharynx is the primary location of infection and also 
viral replication. EBV infects primary B lymphocytes to form latent 
infections and cause proliferation [10, 11]. This patient was previously a 
smoker, and had history of consuming salted fish since childhood, because 
it is easily obtained around his home by the sea.  
Symptoms of NPC are related to the anatomical location of the primary 
tumor and metastasis. Symptoms that often appear can be grouped into four 
categories, 1) Ear symptoms; 2) Nasal symptoms; 3) Symptoms of 
Neurology/Nerves, these symptoms are associated with cranial nerve 
involvement around 20%; 4) A painless lump in the neck found for more 
than 50% of NPC patients. Enlargement of the lymph nodes is usually in the 
upper part of the neck, according to the location of the tumor (ipsilateral), 
but not infrequently bilateral. Other symptoms can include general 
symptoms of malignancy such as weight loss and anorexia [10, 14]. Early 
symptoms of NPC are often not specific and missed, most patients come 
when there is a lump in the neck and are generally advanced stage [14]. 
From clinical examination on the patient, we found a number of symptoms 
related to NPC, there were symptoms of nose, ear, cranial nerve and neck. 
This patient experienced recurrent nosebleeds, hearing disorders and 
earfullness. Chronic complaints of rhinorea were accompanied by 
mucopurulent secretions, nasal obstruction and hyposmia. Some of these 
symptoms were not specific so the discovery during early case was difficult. 
On the other hand patient also suffer from chronic rhinosinusitis 
accompanied by a polyp which further obscures the initial symptoms of 
NPC. Then when the patient experienced a neck lump accompanied by 
recurrent nosebleeds, of course health workers think of the possibility of 
other diagnosis rather than just a chronic rhinosinusitis. The patient’s neck 
lump was painless, ipsilateral and found on level II of the neck as most of 
the cases. 
Examination of the primary tumor in the nasopharynx can be done by 
posterior rhinoscopy and nasopharyngoscopy. Examination with posterior 
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rhinoscopy is often found to be difficult because what is seen is only a 
picture or shadow on the glass. Nasopharyngoscopic examination with 
flexible fibrescope or rigid hopkins endoscope 00 and 300 is required [9, 
15]. We chose the nasopharyngoscope examination using rigid hopkin 00 
scope for better visualization. 
Radiological examination is needed to obtain information on the 
presence of tumors, expansion, and recurrence after therapy. Radiological 
examination for nasopharyngeal carcinoma consists of plain skull, CT scan, 
MRI, and PET scan. CT scan has the advantage and high diagnostic value 
of distinguishing various densities in the nasopharynx and assessing the 
extent of the tumor, spreading to the neck lymph nodes, bone destruction 
and intracranial spread [10, 15, 16]. We performed head and neck CT scan 
with contrast on this patient focused on the nasopharyngeal area, there’s no 
allergy incidence due to the substance.  
Definitive diagnosis of NPC is based on examination of tumor tissue in 
the nasopharynx (found malignant cells) obtained from tissue biopsy results. 
Patients who show positive serological results, but negative biopsy still 
cannot be considered to suffer from NPC and are not allowed to undergo 
radiotherapy. Such patient must be closely observed. There are several types 
of methods for histology and cytology examination, such as biopsy, 
washing, suction, and sweeping ("brush"). For small nasopharyngeal tumors 
or residual tumors, a biopsy technique with nasopharyngoscopy is more 
accurate because the sensitivity of this method is 95% [17]. We performed 
a direct nasalendoscopy for evaluation of the nasal cavity and nasopharynx 
area, followed by biopsy because there was a mass on nasal cavity and 
nasopharynx. This technique is carried out by local anesthetic, it is more 
accurate with light sources and monitors, and uses a large enough cunam 
(Takahashi or Blakesley forceps) so that it can be directed to a place that is 
suspected correctly. Biopsy is done through the nose (transnasal).  
The World Health Organization (WHO) divides the NPC into three 
types. Type I is squamous cell carcinoma with good to moderate 
keratinization and produces a lot of keratin inside and outside the cell. Type 
II is good and medium differentiated squamous cell carcinoma without 
keratinization. It often resembles a picture of transitional cell carcinoma. 
Type III is undifferentiated NPC, also known as anaplastic type and poorly 
differentiated [18, 19]. This type of carcinoma has the ability of invasion 
and metastasis compared to other types, closely related to lymphoid tissue 
called lymphoepithelioma [9]. WHO type III is the most frequent and 
endemic histopathology type, especially in Southeast Asia [7]. This patient 
biopsy result show Type III nasopharyngeal carcinoma, an undifferentiated 
NPC, as the most frequent type found in all cases.  
From the CT scan result, we found that the primary tumor has infiltrated 
intracranially through the cavernous sinus. Then there is metastasis to the 
regional area marked by enlargement of neck node level II (upper jugular) 
where the largest dimension is about 6 cm. The presence of intracranial 
involvement and regional lymph node involvement shows the type III 
carcinoma invasion ability. In determining distant metastases, only lung and 
liver examination and retroperitoneal lymph nodes were examined, but 
involvement of bones not performed due to limited facilities. Clinical stage 
in NPC is very important for therapy and evaluation of therapy. TNM 
assessment stage classification system (tumor size, involved lymph node, 
metastasis): primary tumor (T), regional lymph node (N), metastasis (M). 
According to the American Joint Committee on Cancer (AJCC) 2017; T4 
NPC is a tumor that has an intracranial extension, there is involvement of 
the cranial, hypopharyngeal, orbital, parotid glands, and/or extensive 
infiltration of connective tissue across the lateral surface of the lateral 
pterygoid muscle. For cervical lymph node (LN) involvement, N1 is 
unilateral metastasis and or unilateral or bilateral retropharyngeal LN 
metastasis, <6 cm in size, above the caudal border of the cricoid cartilage, 
while M0 has no distant metastases. The division of stages for NPC is: stage 
0 (Tis N0 M0), stage I (T1 N0 M0), stage II (T0, T1 N1 M0, T2 N0, N1 
M0), stage III (T0, T1, T2 N2 M0, T3 N0, N1, N2 M0), Stage IVA (T4 N0, 
N1, N2 M0, all T N3 M0), stage IVB (all T, all N M1) [5]. We concluded 





















Picture 6. NPC Management Algorithm [5]. 
Radiotherapy is the main choice, especially for undifferentiated NPC 
(WHO type III), because it is radiosensitive. Radiotherapy is performed at 
an early stage (stage I and II). Indications for chemotherapy in NPC include 
advanced stages (stage III and IV), accompanied or suspected distant, 
persistent, and recurrent metastases [10, 20, 21]. Advanced NPC 
management (stage III and IV) is combination chemotherapy with 
radiotherapy. Chemotherapy can be given before, during, or after radiation 
called neoadjuvant, concurrent, and adjuvant chemotherapy. Current 
recommendations for using cisplatin, 5-fluorouracil, taxane, gemcitabine, 
vinorelbine chemotherapy [20]. Based on the algorithm, patients are 
planned for chemoradiation therapy with a choice of concurrent 
chemoradiation techniques followed by adjuvant chemotherapy or induction 
chemotherapy followed by chemo/radiotherapy. But the prognosis of this 
patient was not very good, we can see in the following information.  
The prognosis of patients with NPC depends on the clinical stage when 
the diagnosis is made. More than 80% of therapeutic success occurs in the 
early stages (I-II) and the success rate is reduced by 40% if the patient is 
found at an advanced stage (III-IV) [6]. Five-year survival rate at stage I, II, 
III, and IV obtained around 72%, 64%, 62%, and 38% [22]. 
3. CONCLUSION 
It was reported that a 58-year-old male patient diagnosed with stage 4A 
nasopharyngeal carcinoma and chronic rhinosinusitis with nasal polyp, was 
planned for advanced stage management. Nasopharyngeal carcinoma is 
often undiagnosed at an early stage because the symptoms are not specific 
and the examination of the nasopharynx is difficult. The presence of 
comorbidities in the area around the nasopharynx can obscure the clinical 
symptoms of this malignancy, such as chronic rhinosinusitis with polyps, so 
strengthening early detection in the community as well as in primary and 
advanced health facilities is important. 
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